PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tailor-made pharmaceuticals as basis for novel antidepressants

SAFit-ligands provide the foundation for a mechanistically novel treatment of stress-related psychiatric disorders

Tailor-made pharmaceuticals as basis for novel antidepressants
2014-12-02
(Press-News.org) This news release is available in German.

The FK506-binding protein 51 (FKBP51) is an established risk factor for stress-related psychiatric disorders such as major depression. Drug discovery for FKBP51 has been hampered by the inability to pharmacologically differentiate against the very similar functional counterplayer FKBP52. Scientists at the Max Planck Institute of Psychiatry in Munich have now developed the first potent and highly selective inhibitor of FKBP51. The so-called SAFit-ligand inhibits FKBP51 enhancing growth of neuronal cell cultures and improving stress-coping behavior in mice. These findings provide the structural and functional basis for the development of mechanistically novel antidepressants.

FKBP51 and FKBP52 are proteins which regulate multiple cellular activities. Most importantly in the context of psychiatric diseases, they interact in an antagonistic manner with receptors for stress hormones in the brain. FKBP51 inhibits while FKBP52 enhances the activity of the glucocorticoid receptor, thus playing a major role in the regulation of stress responses.

For the first time, scientists around Felix Hausch, Project Group Leader at the Max Planck Institute of Psychiatry and lecturer at the Ludwig-Maximilians-University in Munich, developed highly selective inhibitors of FKBP51 by an induced-fit mechanism. "We initially used a chemical genetics approach and then, step by step, improved the fitting of our inhibitors," describes Steffen Gaali, post-doctoral student in the project group of Felix Hausch and first author of the current study. "Finally the most potent ligand SAFit, a selective Antagonist of FKBP51 by induced fit, had a more than 10,000-fold selectivity for FKBP51 over FKBP52." SAFit exactly fits into a pocket of FKBP51 by pushing out one of the protein's amino acid side chains. This conformational change cannot occur in the FKBP52 protein.

In further experiments, the researchers investigated the characteristics and effects of the SAFit-ligand. In cell culture, SAFit potently stimulated the differentiation of neuronal cell lines. Unlike former inhibitors of FKBP51, the new pharmacological agent did not show any immunosuppressive side-effects. Further, SAFit displayed antidepressant-like activity in mice. By inhibiting FKBP51, the protein's inhibitory effect on the glucocorticoid receptor is reduced in the brain. Thus, SAFit enhances the regulation of one of the key stress-coping mechanisms, the HPA axis.

"Depression is likely a biologically heterogeneous disease and a major shortcoming is the inability to match antidepressant agents to the specific underlying biological alterations," explains Felix Hausch. "Patients with FKBP51-hyperinducing gene variants or with a hyperactive HPA axis can be clinically identified by genotyping for FKBP51 and/or the Dex-CRF test." Taken together, by generating the SAFit-inhibitor, the Max Planck scientists provide the proof-of-principle for selective FKBP51 inhibitors as a mechanistically novel treatment for stress-related psychiatric disorders.

Further Information (HPA axis and Dex-CRF test) The hypothalamic-pituitary-adrenal axis (HPA axis) is a complex set of interactions among the hypothalamus, the pituitary gland and the adrenal glands. The interactions among these organs play a major role in the control of reactions to stress and regulate many processes, including digestion, the immune system, mood or emotions. The stress-induced release of corticotropin-releasing factor (CRF) by the hypothalamus leads to increased cortisol production in the adrenal glands. Cortisol itself facilitates an adaptive phase in which alarm reactions including the immune response are suppressed, allowing the body to attempt countermeasures against the stress.

The activity of the HPA axis can be measured with the Dex-CRF test. The release of cortisol is significantly higher in some groups of depressed patients than in non-depressed controls, indicating hyperactivity of the HPA axis.

INFORMATION:

Original publication:

S. Gaali, A. Kirschner, S. Cuboni, J. Hartmann, C. Kozany, G. Balsevich, C. Namendorf, P. Fernandez-Vizarra, C. Sippel, A.S. Zannas, R. Draenert, E.B. Binder, O.F.X. Almeida, G. Rühter, M. Uhr, M.V. Schmidt, C. Touma, A. Bracher, F. Hausch.

Selective inhibitors for the psychiatric risk factor FKBP51 enabled by an induced-fit mechanism

Nature Chemical Biology, 1 December 2014 | http://dx.doi.org/10.1038/nchembio.1699


[Attachments] See images for this press release:
Tailor-made pharmaceuticals as basis for novel antidepressants

ELSE PRESS RELEASES FROM THIS DATE:

Turn back the molecular clock, say Argentina's plant fossils

Turn back the molecular clock, say Argentinas plant fossils
2014-12-02
Molecular clocks -- based on changes in genetic material -- indicate much younger ages for a wide variety of plants found as fossils in southern Argentina than do the solid, geologic dates of those fossils, according to geoscientists who surveyed recent paleobotanical discoveries in Patagonia. The finding suggests serious biases in molecular clocks, which are heavily used to date many kinds of living things. It also directly refutes a widely-held idea about how most Southern Hemisphere plant and animal groups attained their current distributions. Geologists date fossils ...

Revealed: How bacteria drill into our cells and kill them

2014-12-02
A team of scientists has revealed how certain harmful bacteria drill into our cells to kill them. Their study shows how bacterial 'nanodrills' assemble themselves on the outer surfaces of our cells, and includes the first movie of how they then punch holes in the cells' outer membranes. The research, published today in the journal eLife, supports the development of new drugs that target this mechanism, which is implicated in serious diseases. The team brings together researchers from UCL, Birkbeck, University of London, the University of Leicester, and Monash University ...

Study finds insects play important role in dealing with garbage on NYC streets

2014-12-02
In the city that never sleeps, it's easy to overlook the insects underfoot. But that doesn't mean they're not working hard. A new study from North Carolina State University shows that insects and other arthropods play a significant role in disposing of garbage on the streets of Manhattan. "We calculate that the arthropods on medians down the Broadway/West St. corridor alone could consume more than 2,100 pounds of discarded junk food, the equivalent of 60,000 hot dogs, every year - assuming they take a break in the winter," says Dr. Elsa Youngsteadt, a research associate ...

If you are having a severe allergic reaction, you need epinephrine first and fast

2014-12-02
ARLINGTON HEIGHTS, Ill. (December 2, 2014) - If you are one of the millions of Americans who experiences a severe allergic reaction to food, latex or an insect sting, you should know the first line of defense in combating the reaction is epinephrine. Unfortunately, not all medical personnel know how important epinephrine is in bringing an allergic reaction under control. According to new guidelines published in the Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), the fast administration ...

Alcohol abuse linked to newly identified gene network

2014-12-02
AUSTIN, Texas -- Researchers at The University of Texas at Austin have identified a network of genes that appear to work together in determining alcohol dependence. The findings, which could lead to future treatments and therapies for alcoholics and possibly help doctors screen for alcoholism, are being published this week in the journal Molecular Psychiatry. By comparing patterns of genetic code from the brain tissue of alcoholics and nonalcoholics, the researchers discovered a particular set of genes co-expressed together in the individuals who had consumed the most ...

Even mild coronary artery disease puts diabetic patients at risk

2014-12-02
CHICAGO - According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA). Researchers at the University of British Columbia and St. Paul's Hospital in Vancouver analyzed data from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) Registry, ...

3-D mammography improves cancer detection in dense breasts

3-D mammography improves cancer detection in dense breasts
2014-12-02
CHICAGO - A major new study being presented at the annual meeting of the Radiological Society of North America (RSNA) has found that digital breast tomosynthesis, also known as 3-D mammography, has the potential to significantly increase the cancer detection rate in mammography screening of women with dense breasts. Breasts are considered dense if they have a lot of fibrous or glandular tissue but not much fatty tissue. Research has shown that dense breasts are more likely to develop cancer, a problem compounded by the fact that cancer in dense breasts can be difficult ...

Risk-based screening misses breast cancers in women in their forties

Risk-based screening misses breast cancers in women in their forties
2014-12-02
CHICAGO - A study of breast cancers detected with screening mammography found that strong family history and dense breast tissue were commonly absent in women between the ages of 40 and 49 diagnosed with breast cancer. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA). "Screening recommendations for this age group continue to be debated," said Bonnie N. Joe, M.D., Ph.D., associate professor in residence and chief of women's imaging at University of California, San Francisco (UCSF). "Recent publications ...

Patients take control of their medical exam records

2014-12-02
CHICAGO - Patients value direct, independent access to their medical exams, according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA). Fragmentation of health information among physicians, healthcare institutions or practices, and inefficient exchange of test results can decrease quality of care and contribute to high medical costs. Improving communications and giving patients more control over their care are critical goals of health IT initiatives. "Easy and timely electronic access to an online unified source of ...

Perceptions, referrals by medical providers affect mental-health treatment disparities

2014-12-02
Disparities in mental-health treatment are known to be associated with patients' racial and ethnic backgrounds. Now, a large study by researchers with UC Davis has found one possible reason for those disparities: Some racial and ethnic minorities are less likely to be assessed and referred for treatment by their medical providers. The study of more than 9,000 diverse individuals, including Latinos, African-Americans, Asian-Americans and non-Hispanic whites, found that patients of different racial and ethnic backgrounds reported experiencing differing treatment approaches ...

LAST 30 PRESS RELEASES:

The Lancet: Tens of thousands of children aged under five suffering acute malnutrition in Gaza, recent estimates suggest

Prostate testing may not target those most likely to benefit, warn experts

Global analysis shows hidden damage from men’s alcohol use

DRI recognizes Ashley Cornish as the 2025 Peter B. Wagner Memorial Award Winner for Women in Atmospheric Sciences

Unlocking the blueprint for a powerful plant-based drug

Bringing modern science to vitamin biology: Isha Jain wins NIH Transformative Research Award

University of Houston scientists learn that rare bacterium ‘plays dead’ to survive

Introduced animals change how island plants spread, new global study finds

Mayo Clinic researchers discover ‘traffic controller’ protein that protects DNA, and may help kill cancer cells

Protein sidekick exhibits dual roles in stress granule assembly and disassembly

New hope for MS

Kennesaw State professor receives grant to study cancer origins

Pain and antidepressant drug combo linked to increased seizure risk in older adults

Cancer researchers shape new strategies for immunotherapy

Physical exercise can ‘train’ the immune system

Calm red brocket deer can learn to "Come" and other commands - but the flightiest, most restless individuals struggle

China, the world's largest tea producer, is predicted to experience increases in land suitable for tea-growing under climate change, with the overall range shifting northwards, per AI modeling study

Composing crews for Mars missions

Early humans butchered elephants using small tools and made big tools from their bones

1,000-year-old gut microbiome revealed for young man who lived in pre-Hispanic Mexico

Bears and pandas in captivity develop significantly different gut microbiomes compared to their wild counterparts, and giant pandas in particular have less diverse microbiomes than their wild counterp

Prenatal and postnatal support apps might not work

Dancing dust devils trace raging winds on Mars

Raging winds on Mars

Real-time biopsies uncover hidden response to glioblastoma therapy

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

Novel immunotherapy combination destroys colorectal liver metastases

Farmed totoaba could curb poaching

Avalanches: user-carried safety device increases survival time fivefold

It’s all in your head: Select neurons in the brainstem may hold the key to treating chronic pain

[Press-News.org] Tailor-made pharmaceuticals as basis for novel antidepressants
SAFit-ligands provide the foundation for a mechanistically novel treatment of stress-related psychiatric disorders